CIRM Announces Recommendations from Strategic Allocation Framework. South San Francisco, CA, September 27, 2024 – The California Institute for Regenerative Medicine (CIRM), one ...

CIRM is governed by 35 dedicated Californians representing patients, researchers and the biotechnology industry whose knowledge, passion and commitment to CIRM’s mission has guided the organization ...

Dr. Xianmin Zeng, associate professor at the Buck Institute for Research on Aging answers your questions about Parkinson’s disease and stem cell research. Zeng has a CIRM research grant to develop a ...

Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following: Once we have called for public comment, members of the ...

移植干细胞的实时成像对于了解它们在体内与宿主环境的相互作用、跟踪细胞命运和功能以及在临床环境中成功输送和安全监测至关重要。在这项研究中，我们使用生物发光（BLI）和磁共振成像（MRI）来可视化中风受损大鼠大脑中移植的人胚胎干细胞（hESC）衍生 ...

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem ...

For details and agenda items please visit our Public Meetings Page.

ReMIND-L (DISC4) applications now closed. ReMIND-X applications expected to post in Q4 2024. The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world-class ...

The California Institute for Regenerative Medicine (CIRM) is funding regenerative medicine and gene therapy research to improve the lives of Sickle Cell patients in California and the world. Sickle ...

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and ...

Generating new stem cell lines is a major focus of many CIRM-funded researchers. Learn why these new lines are considered so important as we accelerate discoveries from the lab bench to the patient’s ...

Manufacturing Network Grant Dr. Dhruv Sareen A comprehensive biomanufacturing center solving bottlenecks in cell and gene therapy manufacturing to accelerate new therapies for California patients ...